Endometriosis is not one disease.
Most women with endometriosis are treated as if they all have the same disease. They do not.
For too long, endometriosis care has relied on surgical findings rather than individual biology. Perita Bio is working on changing that. We perform data analytics using the results of molecular testing to help better understand the biology of each patient's endometriosis, and present the results to her treating physician, who decides how to use it.
What we hear from patients
For 10 years, they experienced debilitating periods and pain during sex, yet never received a diagnosis.
They underwent three pelvic surgeries, but the pain returned after each one.
They tried four hormonal therapies; some worsened their condition, and none provided relief.
Their fatigue, bloating, and bowel and bladder pain were all dismissed as unrelated.
They were told their disease is mild, but their pain has been anything but.
This is who we built Perita for.
Endometriosis care still relies heavily on symptoms, imaging, and surgical findings, which provide only a partial picture of this whole-body disease. Bringing the biology driving their condition into view enables their physician to make a more informed and personalized treatment decision.
Who Perita works with
Perita is designed for women and non-binary people with a uterus who have endometriosis that has not been biologically characterized. Physicians who want a deeper picture than current diagnostics provide.
Not built for acute surgical emergencies, or for cases where additional molecular detail would not change the clinical conversation.
Why this? Why now?
Endometriosis affects roughly one in ten women. We now have precision tools that read the disease at cellular and spatial depth, across its many forms, from deep infiltrating endometriosis to the ovarian endometrioma, sometimes called a chocolate cyst, to chronic pelvic pain that outlasts every treatment tried. The standard of care has not caught up.
Perita Bio was built to bring Deep Endometriosis Characterization™ to a disease the field has under-characterized for decades.
Frequently asked questions
No. Perita is not a medical provider and does not practice medicine and therefore does not provide medical care and does not prescribe or order tests. We perform data analytics on the results from molecular testing to help their treating physician better understand the biology of a patient's disease. Their physician retains full clinical authority. Any physician involvement in their care happens through clinical entities independent of Perita Bio, under their own professional responsibility.
Each patient's situation and needs are unique. We discuss the process and the cost during the first discovery conversation, after reviewing their clinical history and understanding the characterization they are asking for. Our approach is not right for everyone, and we are direct in cases where we do not believe we can add meaningful value.
Not currently. Perita's services are not covered by insurance. We are actively exploring how our approach may fit into existing reimbursement frameworks. For now, every patient we work with pays out of pocket or through other arrangements we discuss case by case.
Most of the patients we work with already have a confirmed diagnosis and surgical staging and want biological analytics beyond what staging shows. Some come to us with suspected or silent endometriosis, based on symptoms and imaging. A confirmed diagnosis or formal referral is not required to begin a conversation.
Specific testing to be performed is determined by a patient's treatment provider. Our services typically rely on data generated from blood, fluid, or microbiome samples collected during clinical visits or procedures. Often, this can begin with a blood draw alone. The deepest level of molecular analysis works from endometriotic lesion tissue obtained during surgery, usually a laparoscopy. What is right for a given patient is part of the discovery conversation.
From sample collection to the Deep Endometriosis Characterization™ Report usually takes four to eight weeks, depending on the depth of the analysis. For patients we work with over time, the characterization continues at defined intervals.
Each patient decides how their data is used, and can consent to or opt out of sharing their de-identified molecular profile with the longitudinal research dataset Perita is building. Data is handled under strict privacy protocols developed with our Scientific Advisory Board and consistent with industry practices. A patient who declines to contribute still receives their report.
Endometriosis is typically characterized by anatomy. Perita characterizes it by biology. Our Deep Endometriosis Characterization™ gives the treating physician a more complete picture of what is driving a patient's disease, delivered as a written Report. What the physician does with it is their decision, made with the patient.